Brief Report: Virologic Impact of the Dolutegravir Transition: Prospective Results From the Multinational African Cohort Study

The real-world impact on viral suppression of switching from non–dolutegravir-based therapy to tenofovir/lamivudine/dolutegravir (TLD) is not thoroughly characterized in Africa. We described the virologic consequences of switching regimens in the African Cohort Study (AFRICOS), an observational coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Esber, Allahna, Dear, Nicole, Shah, Neha, Kibuuka, Hannah, Maswai, Jonah, Owuoth, John, Singoei, Valentine, Bahemana, Emmanuel, Iroezindu, Michael, Crowell, Trevor A., Polyak, Christina S., Cavanaugh, Joseph S., Ake, Julie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561234/
https://www.ncbi.nlm.nih.gov/pubmed/35980350
http://dx.doi.org/10.1097/QAI.0000000000003065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561234/
https://www.ncbi.nlm.nih.gov/pubmed/35980350
http://dx.doi.org/10.1097/QAI.0000000000003065

Ejemplares similares